Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Young David Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2023 4 Young David (President & CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns: Bought 40,000 shares @ $0.8, valued at $32k
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Young David (President & CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns: Granted 25,350 restricted stock units @ $0
Granted 24,030 restricted stock units @ $0
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2022 4 Young David (President & CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns: Exercised 7,601 shares @ $0
Paid exercise price by delivering 2,531 shares @ $3.17, valued at $8k
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/11/2022 4 Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns: Granted 247,841 restricted stock units @ $0
04/04/2022 4 Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns: Granted 4,286 restricted stock units @ $0
Granted 10,715 restricted stock units @ $0
01/04/2022 4 Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns: Granted 6,722 restricted stock units @ $0
10/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/09/2021 4 Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.
Txns: Granted 8,572 restricted stock units @ $0
Granted 12,858 restricted stock units @ $0
Granted 1,907 restricted stock units @ $0
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2014 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Disposed/sold 70,991 shares @ $0
Disposed/sold 32,750 shares @ $0
Disposed/sold 14,000 shares @ $0
Disposed/sold 1,500 options to buy @ $5.77, valued at $8.7k
Disposed/sold 22,500 options to buy @ $9.31, valued at $209.5k
Disposed/sold 71,000 options to buy @ $4.54, valued at $322.3k
Disposed/sold 85,416 options to buy @ $14.24, valued at $1.2M
Disposed/sold 74,375 options to buy @ $35.78, valued at $2.7M
06/26/2014 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Sold 6,000 shares @ $91.9606, valued at $551.8k
Exercised 6,000 options to buy @ $4.54, valued at $27.2k
03/18/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
03/05/2014 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Exercised 6,000 options to buy @ $5.77, valued at $34.6k
02/26/2014 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Granted 14,000 shares @ $0
Disposed/sold 16,667 shares @ $0
Paid exercise price by delivering 17,127 shares @ $79.46, valued at $1.4M
Sold 6,000 shares @ $78.8816, valued at $473.3k
Exercised 6,000 options to buy @ $4.54, valued at $27.2k
01/31/2014 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Exercised 10,000 options to buy @ $5.77, valued at $57.7k
Exercised 10,000 options to buy @ $9.31, valued at $93.1k
01/28/2014 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Sold 6,000 shares @ $64.3824, valued at $386.3k
Exercised 6,000 options to buy @ $4.54, valued at $27.2k
11/21/2013 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Exercised 15,000 options to buy @ $5.77, valued at $86.6k
11/15/2013 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Sold 100,000 shares @ $62.4003, valued at $6.2M
Exercised 100,000 options to buy @ $4.54, valued at $454k
03/08/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
02/26/2013 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Granted 21,332 shares @ $0
Granted 25,000 shares @ $0
08/14/2012 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Exercised 625 options to buy @ $1.47, valued at $918.8
Exercised 10,000 options to buy @ $4.54, valued at $45.4k
05/01/2012 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Sold 70,000 shares @ $42.81, valued at $3M
Exercised 70,000 options to buy @ $4.54, valued at $317.8k
02/17/2012 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Granted 90,000 options to buy @ $35.78, valued at $3.2M
Granted 20,000 options to buy @ $35.78, valued at $715.6k
11/02/2011 4 Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC
Txns: Sold 75,000 shares @ $41.03, valued at $3.1M
Sold 4,724 shares @ $41.4, valued at $195.6k
Exercised 75,000 options to buy @ $4.54, valued at $340.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy